SevenBridge Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.6M | Buy |
8,963
+9
| +0.1% | +$9.2K | 1.56% | 11 |
|
|
2026
Q1 | $8.25M | Buy |
8,954
+230
| +3% | +$233K | 1.29% | 18 |
|
|
2025
Q4 | $9.27M | Buy |
8,724
+370
| +4% | +$354K | 1.49% | 13 |
|
|
2025
Q3 | $8.5M | Buy |
8,354
+1,162
| +16% | +$865K | 1.4% | 12 |
|
|
2025
Q2 | $4.6M | Buy |
7,192
+1,116
| +18% | +$867K | 0.81% | 29 |
|
|
2025
Q1 | $4.59M | Buy |
6,076
+1,403
| +30% | +$1.17M | 0.9% | 28 |
|
|
2024
Q4 | $4.04M | Sell |
4,673
-303
| -6% | -$251K | 0.76% | 41 |
|
|
2024
Q3 | $4.14M | Buy |
4,976
+561
| +13% | +$504K | 0.8% | 37 |
|
|
2024
Q2 | $3.5M | Sell |
4,415
-7,800
| -64% | -$6.24M | 0.77% | 40 |
|
|
2024
Q1 | $8.98M | Sell |
12,215
-170
| -1% | -$121K | 2.03% | 8 |
|
|
2023
Q4 | $7.22M | Hold |
12,385
| – | – | 1.71% | 10 |
|
|
2023
Q3 | $6.65M | Hold |
12,385
| – | – | 1.72% | 11 |
|
|
2023
Q2 | $5.81M | Sell |
12,385
-165
| -1% | -$69.2K | 1.5% | 18 |
|
|
2023
Q1 | $4.31M | Sell |
12,550
-985
| -7% | -$332K | 1.19% | 23 |
|
|
2022
Q4 | $4.95M | Sell |
13,535
-84
| -0.6% | -$29.8K | 1.45% | 19 |
|
|
2022
Q3 | $4.4M | Buy |
13,619
+12,000
| +741% | +$3.8M | 1.49% | 17 |
|
|
2022
Q2 | $525K | Hold |
1,619
| – | – | 0.21% | 91 |
|
|
2022
Q1 | $464K | Sell |
1,619
-300
| -16% | -$77.2K | 0.16% | 99 |
|
|
2021
Q4 | $530K | Sell |
1,919
-21
| -1% | -$5.32K | 0.16% | 110 |
|
|
2021
Q3 | $448K | Hold |
1,940
| – | – | 0.15% | 110 |
|
|
2021
Q2 | $445K | Sell |
1,940
-43
| -2% | -$8.64K | 0.15% | 114 |
|
|
2021
Q1 | $370K | Hold |
1,983
| – | – | 0.13% | 113 |
|
|
2020
Q4 | $335K | Buy |
1,983
+300
| +18% | +$44.8K | 0.13% | 115 |
|
|
2020
Q3 | $249K | Hold |
1,683
| – | – | 0.11% | 122 |
|
|
2020
Q2 | $276K | Hold |
1,683
| – | – | 0.14% | 110 |
|
|
2020
Q1 | $233K | Hold |
1,683
| – | – | 0.13% | 114 |
|
|
2019
Q4 | $221K | Buy |
+1,683
| New | +$195K | 0.06% | 144 |
|
|
2019
Q3 | – | Sell |
-1,683
| Closed | -$186K | – | 384 |
|
|
2019
Q2 | $186K | Hold |
1,683
| – | – | 0.07% | 162 |
|
|
2019
Q1 | $218K | Hold |
1,683
| – | – | 0.08% | 139 |
|
|
2018
Q4 | $195K | Sell |
1,683
-25
| -1% | -$2.79K | 0.12% | 119 |
|
|
2018
Q3 | $183K | Hold |
1,708
| – | – | 0.1% | 136 |
|
|
2018
Q2 | $146K | Hold |
1,708
| – | – | 0.08% | 156 |
|
|
2018
Q1 | $132K | Sell |
1,708
-100
| -6% | -$8.05K | 0.08% | 161 |
|
|
2017
Q4 | $153K | Hold |
1,808
| – | – | 0.08% | 156 |
|
|
2017
Q3 | $155K | Hold |
1,808
| – | – | 0.09% | 154 |
|
|
2017
Q2 | $149K | Hold |
1,808
| – | – | 0.09% | 153 |
|
|
2017
Q1 | $154K | Hold |
1,808
| – | – | 0.1% | 145 |
|
|
2016
Q4 | $145K | Hold |
1,808
| – | – | 0.11% | 154 |
|
|
2016
Q3 | $145K | Hold |
1,808
| – | – | 0.11% | 153 |
|
|
2016
Q2 | $142K | Buy |
+1,808
| New | +$136K | 0.1% | 165 |
|
Other funds holding LLY
SevenBridge Financial Group's LLY Position: Q2 2026 in Review
SevenBridge Financial Group increased its Eli Lilly (LLY) stake by 0.1% in Q2 2026, buying an estimated $9.2K and bringing the position to 8,963 shares worth $10.6M. The position accounts for 1.56% of the portfolio, ranked #11.
SevenBridge Financial Group first reported a position in LLY in Q2 2016 and has held it in 40 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- SevenBridge Financial Group held 8,963 shares of Eli Lilly worth $10.6M as of Q2 2026.
- SevenBridge Financial Group bought 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
- Eli Lilly made up 1.56% of SevenBridge Financial Group's portfolio in Q2 2026, its #11 holding.
- SevenBridge Financial Group first reported a position in Eli Lilly in Q2 2016 and has held it in 40 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on SevenBridge Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.